locatim ad us vet. solution buvable pour veaux, agneaux, porcelets et cabris
biokema s.a. - antibodies against escherichia coli cs31a, antibodies against escherichia coli k99 (f5), antibodies against escherichia coli o101, antibodies against escherichia coli o9, antibodies against escherichia coli o8, antibodies against escherichia coli o78, antibodies against escherichia coli o15, antibodies against escherichia coli o117, antibodies against escherichia coli o115, antibodies against escherichia coli o86, antibodies against escherichia coli f41, antibodies against escherichia coli att25 (f17), antibodies against the rotavirus, antibodies against the coronavirus - solution buvable pour veaux, agneaux, porcelets et cabris - antibodies against escherichia coli cs31a ≥ 3.1 log10 u., antibodies against escherichia coli k99 (f5) ≥ 2.8 log10 u., antibodies against escherichia coli o101 > 1‘600 u., antibodies against escherichia coli o9 > 1‘600 u., antibodies against escherichia coli o8 > 1‘600 u., antibodies against escherichia coli o78 > 1‘600 u., antibodies against escherichia coli o15 > 1‘600 u., antibodies against escherichia coli o117 > 1‘600 u., antibodies against escherichia coli o115 > 1‘600 u., antibodies against escherichia coli o86 > 1‘600 u., antibodies against escherichia coli f41 > 1‘600 u., antibodies against escherichia coli att25 (f17) > 1‘600 u., antibodies against the rotavirus > 1‘600 u., antibodies against the coronavirus > 1‘600 u., e 218 ≤ 0.8 mg/ml, ad solutionem pro 1 ml. - immunoglobulines pour veaux, agneaux, porcelets et cabris - andere immunologische arzneimittel
locatim plus ad us. vet. solution injectable pour veaux et agneaux
biokema s.a. - antibodies against escherichia coli cs31a, antibodies against escherichia coli k99 (f5), antibodies against escherichia coli o101, antibodies against escherichia coli o9, antibodies against escherichia coli o8, antibodies against escherichia coli o78, antibodies against escherichia coli o15, antibodies against escherichia coli o117, antibodies against escherichia coli o115, antibodies against escherichia coli o86, antibodies against escherichia coli f41, antibodies against escherichia coli att25 (f17), antibodies against the rotavirus, antibodies against the coronavirus - solution injectable pour veaux et agneaux - antibodies against escherichia coli cs31a ≥ 3.1 log10 u., antibodies against escherichia coli k99 (f5) > 2‘560 u., antibodies against escherichia coli o101 > 1‘920 u., antibodies against escherichia coli o9 > 1‘920 u., antibodies against escherichia coli o8 > 1‘920 u., antibodies against escherichia coli o78 > 1‘920 u., antibodies against escherichia coli o15 > 1‘920 u., antibodies against escherichia coli o117 > 1‘920 u., antibodies against escherichia coli o115 > 1‘920 u., antibodies against escherichia coli o86 > 1‘920 u., antibodies against escherichia coli f41 > 1‘920 u., antibodies against escherichia coli att25 (f17) > 1‘920 u., antibodies against the rotavirus > 1‘920 u., antibodies against the coronavirus > 1‘920 u., phenolum ≤ 4.0 mg/ml, ad solutionem pro 1 ml. - immunoglobulines pour veaux et agneaux - andere immunologische arzneimittel
haemate p pulver und lösungsmittel zur herstellung einer injektions- oder infusionslösung
csl behring gmbh - gerinnungsfaktor viii - von-willebrand-faktor u
beriate 200 i.e./ml pulver und lösungsmittel zur herstellung einer injektions- oder infusionslösung
csl behring gmbh - gerinnungsfaktor viii -
rhesonativ 625 i.e./ml injektionslösung
octapharma pharmazeutika produktionsges.m.b.h - immunglobulin -
voncento
csl behring gmbh - menschlichen blutgerinnung faktor viii, human-von-willebrand-faktor - hemophilia a; von willebrand diseases - blood coagulation factors, von willebrand factor and coagulation factor viii in combination, antihemorrhagics - von-willebrand-krankheit (vwd)prophylaxe und behandlung von blutungen oder chirurgischen blutungen bei patienten mit vwd, wenn desmopressin (ddavp) behandlung allein unwirksam oder kontraindiziert. hämophilie a (angeborener faktor-viii-mangel)prophylaxe und behandlung von blutungen bei patienten mit hämophilie a.
mycophenolatmofetil biomo 500 mg filmtabletten
biomo pharma gmbh (3263852) - mycophenolatmofetil (ph.eur.) - filmtablette - teil 1 - filmtablette; mycophenolatmofetil (ph.eur.) (26196) 500 milligramm
mycophenolatmofetil biomo 250 mg filmtabletten
biomo pharma gmbh (3263852) - mycophenolatmofetil (ph.eur.) - filmtablette - teil 1 - filmtablette; mycophenolatmofetil (ph.eur.) (26196) 250 milligramm
octagam 50 mg/ml infusionslösung
octapharma benelux - humane polyvalente immunglobulin - infusionslösung - 50 mg/ml - humane polyvalente immunglobulin 50 mg/ml - immunoglobulins, normal human, for intravascular adm.
octagam 50 mg/ml infusionslösung
octapharma benelux - humane polyvalente immunglobulin - infusionslösung - 50 mg/ml - humane polyvalente immunglobulin 50 mg/ml - immunoglobulins, normal human, for intravascular adm.